Avantor (AVTR)
(Delayed Data from NYSE)
$24.87 USD
+0.15 (0.61%)
Updated May 6, 2024 04:00 PM ET
After-Market: $24.86 -0.01 (-0.04%) 7:58 PM ET
3-Hold of 5 3
C Value C Growth C Momentum B VGM
Brokerage Reports
Avantor, Inc. [AVTR]
Reports for Purchase
Showing records 1 - 20 ( 129 total )
Company: Avantor, Inc.
Industry: Medical Services
Company: Avantor, Inc.
Industry: Medical Services
Provider: Zacks Investment Research
Analyst: Research Department
Company: Avantor, Inc.
Industry: Medical Services
Company: Avantor, Inc.
Industry: Medical Services
Company: Avantor, Inc.
Industry: Medical Services
Provider: Zacks Investment Research
Analyst: Research Department
Company: Avantor, Inc.
Industry: Medical Services
Company: Avantor, Inc.
Industry: Medical Services
Provider: Zacks Investment Research
Analyst: Research Department
Company: Avantor, Inc.
Industry: Medical Services
Company: Avantor, Inc.
Industry: Medical Services
Investor Day: Seems More Than Timely to Increase Focus on Biological Production
Provider: KeyBanc Capital Markets
Analyst: Research Department
Company: Avantor, Inc.
Industry: Medical Services
Company: Avantor, Inc.
Industry: Medical Services
Provider: Zacks Investment Research
Analyst: Research Department
Company: Avantor, Inc.
Industry: Medical Services
Optimized Entry and Exit Levels for AVTR 112123
Provider: Stock Traders Daily
Analyst: Research Department
Company: Avantor, Inc.
Industry: Medical Services
Company: Avantor, Inc.
Industry: Medical Services
Company: Avantor, Inc.
Industry: Medical Services
3Q23 Shows Reasons for Optimism in 2024
Provider: KeyBanc Capital Markets
Analyst: Research Department
Company: Avantor, Inc.
Industry: Medical Services
Company: Avantor, Inc.
Industry: Medical Services
Provider: Zacks Investment Research
Analyst: Research Department
Company: Avantor, Inc.
Industry: Medical Services
Company: Avantor, Inc.
Industry: Medical Services
Company: Avantor, Inc.
Industry: Medical Services
Life Science Earnings Recap: Three Groups of Opportunity Ahead, One Area of Risk (China)
Provider: KeyBanc Capital Markets
Analyst: Research Department